Denator
Gothenburg
About Denator
Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling. Utilizing a patent-pending technology to instantly and completely stop the degradation process and maintain sample stability thereafter, Denator aims to become the leading supplier of instruments and consumables that enable scientists to stabilize biological tissues and fluids at the moment of sampling thereby enhancing the quality and value of subsequent analytical results.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.4M
- Funding stage: Late Stage Venture
- Last round: Grant (Jul 2015)
- Website: denator.com
- Phone: +46707918335
Industries & Categories
Biotechnology, Clinical Trials, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/denator-2434452 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.